Optimal timing of re-planning for head and neck adaptive radiotherapy

Adaptive radiotherapy (ART) for head and neck cancer patients has been studied for over 25 years since proposed by Yan et al in 1997[1]. Current practice of ART is particularly aiming to spare organs at risk (OARs) as the leading purpose or most important benefit [2], but is not yet widely applied in routine clinical practice due to the challenges of identifying: 1) the most relevant candidate patients and 2) the optimal timing of re-planning [3,4]. Previous studies have shown up to 10.6% of head and neck cancer patients require re-planning [56].

Source: Radiotherapy and Oncology - February 8, 2024 Category: Radiology Authors: Yong Gan, Johannes A. Langendijk, Edwin Oldehinkel, Zhixiong Lin, Stefan Both, Charlotte L. Brouwer Tags: Original Article Source Type: research